FIGHTING CANCER EVERYDAY
A growing number of cancer practices are sequencing the DNA of tumors to uncover their genetic abnormalities. The aim: to pair a drug with the specific mutation fueling a patient’s disease.
Corey Wood was an athlete and a college student when she found out she had stage IV non-small cell lung cancer. But a targeted drug has made her tumors shrink away.